Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Pre-operative ribociclib plus letrozole versus chemotherapy: Health-related quality of life outcomes from the SOLTI CORALLEEN trial.
Eur J Cancer. 2022 Oct;174:232-242. doi: 10.1016/j.ejca.2022.07.028. Epub 2022 Sep 5.
Eur J Cancer. 2022.
PMID: 36067616
Clinical Trial.
Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial.
Prat A, Saura C, Pascual T, Hernando C, Muñoz M, Paré L, González Farré B, Fernández PL, Galván P, Chic N, González Farré X, Oliveira M, Gil-Gil M, Arumi M, Ferrer N, Montaño A, Izarzugaza Y, Llombart-Cussac A, Bratos R, González Santiago S, Martínez E, Hoyos S, Rojas B, Virizuela JA, Ortega V, López R, Céliz P, Ciruelos E, Villagrasa P, Gavilá J.
Prat A, et al. Among authors: izarzugaza y.
Lancet Oncol. 2020 Jan;21(1):33-43. doi: 10.1016/S1470-2045(19)30786-7. Epub 2019 Dec 11.
Lancet Oncol. 2020.
PMID: 31838010
Clinical Trial.
Item in Clipboard
SOLTI-1904 ACROPOLI TRIAL: efficacy of spartalizumab monotherapy across tumor-types expressing high levels of PD1 mRNA.
Prat A, Paz-Ares L, Juan M, Felip E, Garralda E, González B, Arance A, Martín-Liberal J, Gavilá J, López-González A, Cejalvo JM, Izarzugaza Y, Amillano K, Corbacho JG, Saura C, Racca F, Hierro C, Sanfeliu E, Gonzalez X, Canes J, Villacampa G, Salvador F, Pascual T, Mesía R, Cervantes A, Tabernero J.
Prat A, et al. Among authors: izarzugaza y.
Future Oncol. 2022 Oct 6. doi: 10.2217/fon-2022-0660. Online ahead of print.
Future Oncol. 2022.
PMID: 36200668
Review.
Item in Clipboard
Prognostic value of Ki-67 according to age in patients with triple-negative breast cancer.
Zenzola V, Cabezas-Quintario MA, Arguelles M, Pérez-Fernández E, Izarzugaza Y, Correa A, García-Foncillas J.
Zenzola V, et al. Among authors: izarzugaza y.
Clin Transl Oncol. 2018 Nov;20(11):1448-1454. doi: 10.1007/s12094-018-1877-5. Epub 2018 Apr 18.
Clin Transl Oncol. 2018.
PMID: 29671222
Item in Clipboard
Late Administration of Trastuzumab Emtansine Might Lead to Loss of Chance for Better Outcome in Patients with HER2-Positive Metastatic Breast Cancer.
Manso L, Sanchez-Muñoz A, Calvo I, Izarzugaza Y, Plata J, Rodriguez C.
Manso L, et al. Among authors: izarzugaza y.
Breast Care (Basel). 2018 Aug;13(4):277-283. doi: 10.1159/000488794. Epub 2018 Jul 13.
Breast Care (Basel). 2018.
PMID: 30319330
Free PMC article.
Review.
Item in Clipboard
Generation and Characterization of Trastuzumab/Pertuzumab-Resistant HER2-Positive Breast Cancer Cell Lines.
Sanz-Álvarez M, Luque M, Morales-Gallego M, Cristóbal I, Ramírez-Merino N, Rangel Y, Izarzugaza Y, Eroles P, Albanell J, Madoz-Gúrpide J, Rojo F.
Sanz-Álvarez M, et al. Among authors: izarzugaza y.
Int J Mol Sci. 2023 Dec 22;25(1):207. doi: 10.3390/ijms25010207.
Int J Mol Sci. 2023.
PMID: 38203378
Free PMC article.
Item in Clipboard
Patritumab deruxtecan in untreated hormone receptor-positive/HER2-negative early breast cancer: final results from part A of the window-of-opportunity SOLTI TOT-HER3 pre-operative study.
Oliveira M, Falato C, Cejalvo JM, Vila MM, Tolosa P, Salvador-Bofill FJ, Cruz J, Arumi M, Luna AM, Guerra JA, Vidal M, Martínez-Sáez O, Paré L, González-Farré B, Sanfeliu E, Ciruelos E, Espinosa-Bravo M, Pernas S, Izarzugaza Y, Esker S, Fan PD, Parul P, Santhanagopal A, Sellami D, Villacampa G, Ferrero-Cafiero JM, Pascual T, Prat A.
Oliveira M, et al. Among authors: izarzugaza y.
Ann Oncol. 2023 Aug;34(8):670-680. doi: 10.1016/j.annonc.2023.05.004. Epub 2023 May 19.
Ann Oncol. 2023.
PMID: 37211044
Free article.
Item in Clipboard
Tumor-Infiltrating Lymphocytes and Immune Response in HER2-Positive Breast Cancer.
Luque M, Sanz-Álvarez M, Morales-Gallego M, Madoz-Gúrpide J, Zazo S, Domínguez C, Cazorla A, Izarzugaza Y, Arranz JL, Cristóbal I, Rojo F.
Luque M, et al. Among authors: izarzugaza y.
Cancers (Basel). 2022 Dec 8;14(24):6034. doi: 10.3390/cancers14246034.
Cancers (Basel). 2022.
PMID: 36551522
Free PMC article.
Review.
Item in Clipboard
Cite
Cite